From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves Darzalex for patients with previously treated multiple myeloma

from FDA

The U.S. Food and Drug Administration granted accelerated approval for Darzalex to treat patients with multiple myeloma who have received at least three prior treatments. Darzalex is the first monoclonal antibody approved for treating multiple myeloma. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063